Clinical trial
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
NCT00898807 is registered in ClinicalTrials.gov with JHSPH Center for Clinical Trials as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
- Lead sponsor
- JHSPH Center for Clinical Trials
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- September 30, 2013
- Enrollment
- 186 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
agitation, alzheimer's disease